Sign in
4

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-005568

SVP Chief Financial Officer sold 1,320 shares at $25.50 ($33,658)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Vairavan Latha · SVP Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-02 Sale : show line 1 in the form 10b5-1 −1,320 $25.50 $33,658 63,607 D
Open-market sales · 1,320 sh · avg $25.50 · $33,658
Loading xslF345X05/wk-form4_1770251062.xml…